
NovoCure Limited NVCR
$ 14.41
-3.13%
Quarterly report 2025-Q2
added 07-24-2025
NovoCure Limited ROE Ratio 2011-2026 | NVCR
Annual ROE Ratio NovoCure Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -46.82 | -57.12 | -20.97 | -14.21 | 1.03 | -3.32 | -56.62 | -54.3 | -92.62 | -44.49 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.03 | -92.62 | -38.94 |
Quarterly ROE Ratio NovoCure Limited
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -37.91 | -35.65 | -28.49 | -41.05 | -45.15 | -49.74 | -38.66 | -44.63 | -38.02 | -29.65 | -12.47 | -18.91 | -16.12 | -14.37 | -14.42 | -6.94 | 0.39 | 8.24 | 13.5 | 14.43 | 6.95 | -0.53 | -8.0 | -23.88 | -77.18 | -130.48 | -183.78 | -179.49 | -177.17 | -174.85 | -172.53 | -178.46 | -216.79 | -255.12 | -293.44 | -291.0 | -242.86 | -194.72 | -146.59 | -215.89 | -253.84 | -209.35 | -82.43 | -82.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.43 | -293.44 | -95.9 |
ROE Ratio of other stocks in the Health care industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
14.47 | - | -2.32 % | $ 107 B | ||
|
Cigna Corporation
CI
|
9.21 | $ 279.23 | -1.65 % | $ 76.5 B | ||
|
Triple-S Management Corporation
GTS
|
6.94 | - | 0.28 % | $ 847 M | ||
|
Magellan Health, Inc.
MGLN
|
20.45 | - | -0.19 % | $ 2.49 B | ||
|
Centene Corporation
CNC
|
12.51 | $ 46.81 | -0.25 % | $ 24.4 B | ||
|
CVS Health Corporation
CVS
|
6.11 | $ 80.31 | -0.36 % | $ 101 B | ||
|
Humana
HUM
|
7.37 | $ 277.28 | -0.1 % | $ 33.4 B | ||
|
Molina Healthcare
MOH
|
26.22 | $ 181.9 | -0.87 % | $ 10.4 B | ||
|
UnitedHealth Group Inc.
UNH
|
14.66 | $ 344.79 | -0.59 % | $ 318 B |